You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

Article info

Article menu

Download PDFPDF

XML
Research Article
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

Authors

  • Sung-Eun Lee Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea PubMed articlesGoogle scholar articles
  • Ji-Young Lim Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Tae Woo Kim Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Da-Bin Ryu Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Sung Soo Park Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea PubMed articlesGoogle scholar articles
  • Young-Woo Jeon Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea PubMed articlesGoogle scholar articles
  • Jae-Ho Yoon Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea PubMed articlesGoogle scholar articles
  • Byung-Sik Cho Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Ki-Seong Eom Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Yoo-Jin Kim Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Hee-Je Kim Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Seok Lee Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Seok-Goo Cho Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea PubMed articlesGoogle scholar articles
  • Dong-Wook Kim Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  • Jong Wook Lee Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea PubMed articlesGoogle scholar articles
  • Chang-Ki Min Department of Hematology, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of Korea 222 Banpodae-ro, Seocho-gu 06591 Seoul Korea Leukemia Research InstituteThe Catholic University of Korea Seoul Korea PubMed articlesGoogle scholar articles
  1. ↵p 82-2-2258-6053 ckmin{at}catholic.ac.kr
View Full Text

Citation

Lee S, Lim J, Kim TW, et al
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
Journal for ImmunoTherapy of Cancer 2019;7:35. doi: 10.1186/s40425-018-0491-y

Publication history

  • Received August 24, 2018
  • Accepted December 20, 2018
  • First published February 7, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.